Laparoscopic Appendectomy near Astoria, NY

Biography: Dr. Ravi P. Kiran is the co-director of the Global Center for Integrated Colorectal Surgery and IBD Interventional Endoscopy at NewYork-Presbyerian/Columbia University Irving Medical Center. Prior to that, he served as chief and program director of the Division of Colorectal Surgery at NewYork-Presbyterian/Columbia University Irving Medical Center for over a decade. He is also the Director of the Center for Innovation and Outcomes Research in the Department of Surgery. Dr. Kiran, a renowned surgeon-scientist with expertise in inflammatory bowel disease, colorectal cancer, and other complicated colorectal conditions, joined NewYork-Presbyterian/Columbia from the Cleveland Clinic, where he was staff surgeon and head of the research section in the Department of Colorectal Surgery and director of its Rupert B. Turnbull Jr. School of Enterostomal Therapy. Dr. Kiran brings a wealth of experience in laparoscopic and open colorectal surgery, anorectal procedures and reoperative abdominal and pelvic surgery. With expertise in inflammatory bowel disease (IBD) like complex Crohn's disease and ulcerative colitis, he specializes in bowel conservation as well as avoiding an ostomy (external bag) for these conditions when others may be unable. Having trained with Dr Victor Fazio at the Cleveland Clinic, he is an expert at pouch procedures. In addition to J and S pouch creation, he has experience in the repair, revision and redo of these pouches when pouch failure occurs. In addition to IBD, he is also expert in the surgical management of primary and recurrent colon and rectal cancer, diverticulitis, enterocutaneous fistula, functional bowel problems including constipation, incontinence and pelvic floor disorders. He is one of only a few highly skilled surgeons world-wide to perform continent ileostomy reservoir procedures and other complex operations to avoid a permanent ostomy after rectal or colon resection. As a researcher, Dr. Kiran has specific interests in surgical outcomes and quality and in evidence-based strategies for inflammatory bowel disease and other conditions. With a joint appointment at Columbia University Vagelos College of Physicians and Surgeons and at Columbia's Mailman School of Public Health, Dr. Kiran facilitates research collaborations in epidemiology between the Department of Surgery and the Mailman School. Dr. Kiran received his medical degree from and completed surgical training at Osmania Medical College in Hyderabad, India, and received advanced training in colorectal surgery in the United Kingdom. He completed his general surgery residency at Yale-Saint Mary's Hospital and Bronx-Lebanon Hospital Center and fellowship training in colorectal surgery at the Cleveland Clinic. He is board certified in surgery and in colon and rectal surgery from the American College of Surgeons (FACS) and the American Society of Colon and Rectal Surgeons (FASCRS) and is a fellow of the Royal Colleges of Surgeons of England and Glasgow. The author of more than 200 peer-reviewed publications, Dr. Kiran is also an editor and reviewer for numerous prominent journals and textbooks. As a student and physician, he has earned several distinctions, including the National Merit Scholarship and Gold Medals during his medical education and surgical training in India, Resident Researcher of the Year during surgical residency, Teacher of the Year in Colorectal Surgery at Cleveland Clinic in 2011, and the ASCRS Travelling Fellow Award in 2012. He has been voted to the list of Best Doctors in New York many times. Dr Kiran has a patient-centered approach to care and is available to see patients at the Main Campus, Midtown and New Jersey colorectal surgery office locations. Watch Video Profile

Biography: Dr. Emond is the Vice Chairman of Surgery at Columbia University. He has over 30 years of experience performing liver transplantation and complex liver and biliary surgery in children and adults, including the first living donor liver transplantation (LDLT) in the United States. Dr. Emond has published extensively in this field and was the co-chair of the NIH A2ALL program for 13 years. In collaboration with the department of Medicine at Columbia, Dr. Emond recruited the leadership of the Columbia Center for Translational immunology that created the foundation for translational and clinical research in transplantation tolerance. This will lead the way to inducing transplant tolerance in liver patients with the mixed chimerism strategy. As Director of Transplantation at the Columbia University Medical Center Dr. Emond's activities foster clinical excellence and research across all 11 of the solid organ transplant programs at the Medical Center. In recognition of his national and international leadership in transplantation, Dr. Emond is the past president of the American Society of Transplant Surgeons, the pre-eminent association of a transplant surgery. Contribution to Science Living donor liver transplantation Dr. Emond has spent a substantial portion of his career developing living donor liver transplantation and studying the safety of the procedure in both the donor and recipient. He participated in the first living donor liver transplant in the United States and focused on refining the techniques of performing living donor liver transplants and split liver transplants. He was the national co-chair of the NIH-sponsored Adult-to-Adult Living Donor Liver Transplantation (A2ALL) consortium from 2002 to 2015 to study the safety and outcomes of living donor liver transplants. Hepatic resection/ischemia Dr. Emond developed techniques for surgical resection of liver tumors and studied the effect of ischemia during resection on postoperative liver function. These studies include the outcomes of the extent of hepatectomy, the biochemical response to major hepatectomy and ischemia-reperfusion injury of the liver in rodent models. He has studied the clinical safety of inducing total vascular exclusion to provide a bloodless field during the liver transection. This has applications in both liver cancer and living donor hepatectomies. Hepatocellular carcinoma treatment Dr. Emond has studied many aspects of managing patients with hepatocellular carcinoma. These studies have included characterizing the risk factors for recurrence of disease following transplantation due to comorbidities and tumor characteristics. The research team has also studied the optimal method of preventing tumor growth in patients with HCC on the liver transplant wait list in addition to optimal strategies of liver allocation to optimize outcomes following liver transplantation. These studies have contributed to proposed changes in UNOS exception point allocation for liver transplant candidates with HCC. Pediatric liver transplantation Dr. Emond helped develop the field of pediatric liver transplantation. Contributions to this field include: the use of living donors for pediatric patients; use of auxiliary liver transplants for metabolic diseases; use of partial liver grafts for pediatric patients; and technical modifications that improved outcomes for this patient population. Visit The Center for Liver Disease and Transplantation at columbiasurgery.org/liver

Biography: Dr. Bret Taback is a nationally recognized surgical oncologist in the New York-Presbyterian/Columbia University Irving Medical Center department of surgery. Dr. Taback is a leader in the clinical management of melanoma, sarcoma and skin/soft tissue tumor surgery. Dr. Taback is the Director of the Melanoma and Sarcoma Program and Director of the Breast Surgery Fellowship. Dr. Taback received his MD degree at Tufts University School of Medicine in Boston , and completed his general surgery residency at Brown University, Rhode Island Hospital. During that time he completed a Basic Science Research Fellowship at Beth Israel Deaconess Medical Center, Harvard Medical School in Boston. Following this, he completed a fellowship in Complex Surgical Oncology at the John Wayne Cancer Institute, Santa Monica, California. Dr. Taback is a member of a number of organizations and societies including Society of Surgical Oncology, American Society of Clinical Oncology and the American Association for Cancer Research. He is also a Fellow of the American College of Surgeons. He has published and authored numerous peer review manuscripts, abstracts and presentations, as well as book chapters over the years in notable publications such as Annals of Surgery, Annals of Surgical Oncology, Cancer Research, Clinical Cancer Research and the Journal of the National Cancer Institute. He is a clinical investigator with SWOG and Alliance for clinical trials. Dr. Taback has served on numerous hospital committees including tumor boards, Institutional Review Boards, Oncology Operations Council and is the American College of Surgeon's Commission on Cancer Physician Liaison for NYP Hospital. Most recently, Dr. Taback is a noted Castle Connolly Top Doctor.